Inventor
Catherine Howsham
Inventor
Horsham, GB
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes29%
PatentTitleYear
10,117,858Pyridine and pyrazine derivative for the treatment of CF2018RE046757'Pyridine and pyrazine derivative for the treatment of CF'20189,643,983'Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives'20179,522,149'Pyrazine derivatives as ENaC blockers'20169,365,552'Pyridine and pyrazine derivative for the treatment of CF'20169,139,586'Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives'20159,056,867'N-substituted heterocyclyl carboxamides'20159,050,339'Pyrazine derivatives as ENaC blockers'20158,901,134'Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders'20148,846,687'Pyrazine compounds as PI3 kinase inhibitors'20148,809,340'Crystalline form'20148,697,687'Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives'20148,664,228'3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases'20148,476,269'Pyridine and pyrazine derivative for the treatment of CF'20138,372,845'Pyrazine derivatives as enac blockers'20138,268,834'Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme'20128,263,585'Organic compounds'20128,247,436'Pyridine and pyrazine derivative for the treatment of CF'20128,236,808'Pyrazine derivatives as ENAC blockers'20128,039,472'Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2018Patents assigned to NOVARTIS AG (20)· patent assignee history
2011–2018Based in Horsham, GB· patent location history
2012–2017Patents assigned to HOWSHAM CATHERINE (13)· patent assignee history
2012–2017Patents assigned to EDWARDS LEE (9)· patent assignee history
2012–2017Patents assigned to BUDD EMMA (8)· patent assignee history
2012–2017Patents assigned to HUNT THOMAS ANTHONY (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 20 | 2011–2018 |
| HOWSHAM CATHERINEself | 13 | 2012–2017 |
| EDWARDS LEE | 9 | 2012–2017 |
| BUDD EMMA | 8 | 2012–2017 |
| HUNT THOMAS ANTHONY | 6 | 2012–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Horsham, GB | 20 | 2011–2018 |